# ArrayPatch

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arraypatch

- Industry: Biotechnology
- Headquarters: Cork, Ireland
- Website: www.array-patch.com
- Total disclosed funding: $4M
- Latest round: Seed (Nov 5, 2026)
- Investors on record: 9

## About

ArrayPatch Ltd, located in Cork, Ireland, specializes in advanced microneedle patch technology, focusing on pain-free drug delivery systems for dermatological applications, particularly targeting nail fungal infections in diabetic patients.ArrayPatch Ltd is dedicated to the development of innovative microneedle patch technology. Founded in 2024 in Cork, Ireland, the company has completed 1 deal, with its most recent funding round occurring on February 10, 2026. The latest funding round was a SEED round, raising EUR 1.9 mn, led by Lakeside Capital with participation from Boole Investment Syndicate, DeepIE Ventures, and Enterprise Ireland. The total amount raised to date is EUR 3.000 mn. The founder's background information is not available.ArrayPatch specializes in innovative microneedle patch technology, specifically through its flagship product, DerMap. This advanced, dissolvable microneedle patch, approximately the size of a small coin, is designed for pain-free drug delivery by penetrating the outer layer of the skin and dissolving to release medication directly at the targeted site. The primary application is in the dermatological market, with an initial focus on treating nail fungal infections, especially in high-risk diabetic patients. The technology distinguishes itself by utilizing microneedles composed entirely of the drug treatment, eliminating the need for polymers found in older delivery systems and enhancing drug loading and efficacy. ArrayPatch aims to address a significant gap in dermatological treatment options, targeting markets in North America and Europe where dermatological innovations are relatively limited.ArrayPatch's revenue generation model revolves around the commercialization of its microneedle patch technology, specifically the ITZ-DerMap™ product designed for treating nail fungus. The company engages in direct partnerships with healthcare professionals and institutions, facilitating B2B transactions that enable the distribution of its products to clinics and hospitals. Through these partnerships, products are sold on a per-unit basis, with financial structures aligned with the healthcare sector's reimbursement frameworks. ArrayPatch’s strategy includes pursuing a fast-track 505(b)(2) regulatory route to expedite the market entry of its products, thereby enhancing its revenue potential as it expands into additional indications such as skin cancer and migraines. The company is supported by recent funding rounds aimed at advancing product development and market penetration, solidifying its financial standing in the healthcare industry.In February 2026, ArrayPatch Ltd raised EUR 3.000 mn in seed funding led by Lakeside Capital, with participation from Enterprise Ireland, Boole Investment Syndicate, and DeepIE Ventures. The funding will be utilized to advance the clinical development of its lead product ITZ-DerMap toward clinical proof of concept for the treatment of nail fungal infections. ArrayPatch aims to launch new products in the near future and expand into markets in North America and Europe, where it sees significant opportunities for growth. The firm is focused on enhancing its product line and exploring additional therapeutic areas to meet unmet medical needs.

## Funding rounds

- Seed, Nov 5, 2026, $1.8M — Lakeside Capital, DeepIE Ventures, Enterprise Ireland, Prof Mark Ledwidge, Spark Venture Funding, The Boole Investment Syndicate, WakeUp Capital, Dr. Mark Ledwidge
- Seed, Feb 10, 2026, $2.2M — Enterprise Ireland, Boole Investment Syndicate, DeepIE Ventures, Lakeside Capital

## Investors

- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- Boole Investment Syndicate — Seed
- DeepIE Ventures (https://capitalatlas.ai/funds/deepie-ventures) — Seed
- Lakeside Capital — Seed
- Prof Mark Ledwidge — Seed
- Spark Venture Funding — Seed
- The Boole Investment Syndicate — Seed
- WakeUp Capital (https://capitalatlas.ai/funds/wakeup-capital) — Seed
- Dr. Mark Ledwidge — Seed